Search results for:

First name: Last name:
Country:
Keywords: Search in:
Year:
Format:
9690 match(es)

2014 PSWC, Melbourne (Australia)

Presentations

April 13

FIP OPENING PLENARY CEREMONY

WORKSHOP 1: BIOSIMILAR MONOCLONAL ANTIBODIES

WORKSHOP 2: CHALLENGES OF POORLY WATER SOLUBLE DRUGS

WORKSHOP 3: TRANSLATIONAL MODELLING

WORKSHOP 4: TRANSPORTERS IN DRUG DISPOSITION

April 14

AUSTRALIAN SHOWCASE: DRUG DISCOVERY AND DEVELOPMENT IN AUSTRALIA

BPS / BPP PLENARY

FIP KEYNOTE: BEYOND COST ARBITRAGE: GLOBALLY NETWORKED POLYCENTRIC R&D ADDRESSING AFFORDABILITY AND ACCESSIBILITY

FIP KEYNOTE: COMPARING NANOPARTICLE AND CLASSIC MICROPARTICLE IN VIVO FATES

FIP KEYNOTE: DRUG DELIVERY TO THE BRAIN: IS THE BLOOD-BRAIN BARRIER A FRIEND OR FOE?

FIP KEYNOTE: REGULATORS, PAYERS AND INDUSTRY

FIP-ED KEYNOTE

KEYNOTE: RE-INVENTING CLINICAL DRUG DEVELOPMENT:IT

MINI-SYMPOSIUM: CHALLENGES IN BIOEQUIVALENCE FOR INHALED PRODUCTS

MINI-SYMPOSIUM: PK-PD TO ENHANCE MODEL-BASED DRUG DEVELOPMENT

MODERATED DEBATE: CARRIER MEDIATED TRANSPORT THROUGH MEMBRANES: THE EXCEPTION OR THE RULE?

PHARMACEUTICAL SCIENCES 2020: AN AMERICAN PERSPECTIVE

PLENARY: MEDICATION SAFETY: CHALLENGES FOR THE 21ST CENTURY

PUBLIC LECTURE: SNAKES, SPIDERS AND OTHER VENOMOUS PREDATORS

ROUND TABLE: THE ROLE OF BIOPHARMACEUTICAL TOOLS IN QUALITY BY DESIGN

SINGAPORE SHOWCASE

SUBMITTED ORAL

SUBMITTED ORALS

SYMPOSIUM: CHALLENGES FOR THE DEVELOPMENT OF DRUGS WITH LOW AQUEOUS SOLUBILITY AND/OR LOW PERMEABILITY

SYMPOSIUM: DOUWE BREIMER FOUNDATION SYMPOSIUM

SYMPOSIUM: EMERGING MARKETS/EAST MEETS WEST

SYMPOSIUM: GENE-BASED THERAPEUTICS: POSSIBILITIES AND CHALLENGES

SYMPOSIUM: PHARMACOEPIDEMIOLOGY: BRIDGING PHARMACEUTICAL SCIENCE AND PRACTICE

SYMPOSIUM: PK-PD FOR SUPPORTING CLINICAL DECISIONS AND POINT-OF-CARE DOSAGE

April 15

ACCELERATING DEVELOPMENT FOR CHINA AND BEYOND:PATIENT, SCIENCE, AND PUBLIC HEALTH

APSA EARLY CAREER RESEARCHER SYMPOSIUM

APSA KEYNOTE

APSA SYMPOSIUM: BARRIER MECHANISMS TEAM UP: INTERPLAY BETWEEN TRANSPORTERS, ENZYMES AND TIGHT JUNCTIONS

APSA SYMPOSIUM: INTRACELLULAR DRUG TRAFFICKING AND TARGETING

BIOSIMILARS - CURRENT TOPICS AND CONTROVERSIES

FIP KEYNOTE: THE FUTURE OF VACCINES

INDIAN SHOWCASE

KEYNOTE: THERAPEUTIC MONOCLONAL ANTIBODIES: WHERE HAVE WE COME, AND WHERE ARE WE GOING?

MINI SYMPOSIUM: NOVEL NANOMATERIALS WITH DRUG DELIVERY APPLICATIONS

MINI SYMPOSIUM: PERSONALIZED MEDICINE IN THE CLINIC: READY FOR PRIMETIME?

MINI-SYMPOSIUM: BIOSIMILARS: CHALLENGES AND OPPORTUNITIES

MINI-SYMPOSIUM: EVOLUTION OF THE BIOSIMILAR REGULATORY LANDSCAPE

PHARMACEUTICAL SCIENCES 2020: A EUROPEAN PERSPECTIVE

ROUND TABLE - INTERCHANGEABILITY OF BIOSIMILARS - YES OR NO?

SUBMITTED APSA ORALS

SUBMITTED ORALS

SUNRISE SESSION: MEET THE EXPERT

Sunrise Session: Meet the Expert

SYMPOSIUM: ACADEMIA AND PHARMA COLLABORATIVE MODELS - FINDING THE RIGHT BALANCE

SYMPOSIUM: DRUG DEVELOPMENT EFFORTS TO COMBAT TROPICAL DISEASES

SYMPOSIUM: ENABLING PERSONALIZED MEDICINE: GETTING THE FRAMEWORK RIGHT?

SYMPOSIUM: IMMUNOGENICITY MITIGATION STRATEGIES FOR BIOSIMILARS

SYMPOSIUM: NANOTECHNOLOGIES FOR DRUG DELIVERY

SYMPOSIUM: SAFETY OF NANOMEDICINES: REALITY CHECK?

April 16

DDA KEYNOTE: BLOCK COPOLYMER MICELLES AS SMART NANO CARRIERS FORTARGETED DRUG DELIVERY

DDA SUBMITTED ORALS

DDA SYMPOSIUM: PULMONARY DRUG DELIVERY

DDA SYMPOSIUM: SELF-ASSEMBLED DRUG DELIVERY SYSTEMS

FIP KEYNOTE: A GENOMICS VIEW OF DRUG THERAPY

FIP KEYNOTE: A GLANCE ON CURRENT PROGRESS OF INNOVATIVE DRUG R&D IN CHINA

FIP KEYNOTE: PHYSICAL PHARMACY AND PHARMACEUTICS, GRAND ACHIEVEMENTS, AND NOW FOR THE FUTURE

FIP KEYNOTE: UNDERSTANDING THE PHYSICOCHEMICAL AND BIOLOGICALDETERMINANTS OF PHARMACOKINETICS: FROM HUMANS TO ORGANS, CELLS AND NANOSYSTEMS

MINI SYMPOSIUM: DRUG DISCOVERY IN ACADEMIA

MINI SYMPOSIUM: MOLECULAR AND FUNCTIONAL IMAGING IN DRUG DEVELOPMENT AND EARLY CLINIC

PHARMACEUTICAL SCIENCES 2020

ROUND TABLE / DEBATE

ROUND TABLE / DEBATE: DOES ALTERED PHYSIOLOGY ALWAYS EQUATE TO ALTERED DRUG DISPOSITION?

ROUND TABLE: IUPHAR / FIP: TRANSLATION THROUGH COOPERATION

SHOWCASE CHINA

SUBMITTED ORALS

SUBMITTED ORALS

SUNRISE SESSION: MEET THE EXPERT

SYMPOSIUM: CROSSING THE BRIDGE

SYMPOSIUM: HERB-DRUG INTERACTIONS: ARE THEY DANGEROUS?

SYMPOSIUM: NATURAL PRODUCTS - SUSTAINABLE USE OF MEDICINAL PLANT RESOURCES

SYMPOSIUM: NEW MOLECULAR AND CELLULAR TARGETS FOR THE TREATMENT OF HUMAN DISEASE

SYMPOSIUM: NON-ADHERENCE - THE LARGEST CONTRIBUTION TO VARIABILITY IN DRUG RESPONSE

SYMPOSIUM: TRANSPORTERS AS MEDIATORS OF CLINICAL DRUG-DRUG INTERACTIONS

Poster

Analytical Sciences and Pharmaceutical Quality

Biotechnology (Vaccine)

Drug Design and Discovery

Formulation Design and Pharmaceutical Technology

Natural Products

Pharmacoepidemiology and Health Technology Assessment

Pharmacokinetics (PK), Pharmacodynamics (PD) and Systems Pharmacology

Pharmacology

Regulatory Sciences - BCS and Biowaivers

Regulatory Sciences - Clinical Bridging Studies

Regulatory Sciences - Dissolution/In vitro drug release

Translational Research and Individualized Medicines

Biography

2013 Dublin (Ireland)

Presentations

August 31

F1- Pharmacy Technicians Symposium Session 1 Part A: The roles of pharmacy technicians in managing complex patients

F1- Pharmacy Technicians Symposium Session 1 Part B : The roles of pharmacy technicians in managing complex patients

F1- Pharmacy Technicians Symposium Session 2 : Complex patient case studies

September 1

F1- Pharmacy Technicians Symposium Session 3 Part A: Collaborative approaches to managing complex patients

F1- Pharmacy Technicians Symposium Session 3 Part B : Collaborative approaches to managing complex patients

F2- Pharmacy and pharamceutical sciences in Ireland

September 2

A1 - Why are patients complex?

B1 - Introduction session: Unmet needs of the complex patient

E3 - Translating expert knowledge into patient care

F12 - How can practitioners provide consumers with proper information on herbals in different regulatory systems

F17 - Presentations from FIP member organisations (Part 1)

F21 - Short oral presentations of the FIP Industrial Pharmacy Section

F5 - The complexity of health challenges in 2020: Are we ready?

F8 - Providing hospital pharmacy services to meet the needs of complex patients: Can the Basel Statements help?

F9 - Pharmacy practice in the face of globalism, ethics and regulation

Posters

September 3

B2 - Healthcare data: Safeguarding confidentiality

B3 - The need for better communication

C1 - Best practice in integrating drug therapy and patient care

C11 - Collaborative approaches to dealing with complex medical conditions

C13 - Diagnostics in individualized medicine and pharmacotherapy: What you need to know

C6 - Anticoagulation: Pharmacists at the bleeding edge of patient care

C7 - Remuneration and implementation of community pharmacy services to complex patients

C8 - Trends in Community Pharmacy: Debating the future of the profession

D1 - Implementing the vision

E1 - Science: The best basis for the best practice?

F11 - The value of real world evidence - will availability of data lead to a paradigm change?

F13 - FIP Host Madsen Medal Lecture

F18 - Presentations from FIP member organisations (Part 2)

F23 - Short oral presentations of the FIP Pharmacy Information Section

F3 - Conclusions of the chief pharmacists' meeting

September 4

C1 - Best practice in integrating drug therapy and patient care

C10 - Complex patients and obstacles to quality use of medicines - a patient‘s perspective

C12 - Computer prompts versus clinical freedom (debate)

C2 - Managing patients with cancer: The role of the pharmacist

C3 - Managing patients with renal impairment: The role of the pharmacist

D2 - High-quality support: The ultimate target of pharmacologistics

D3 - The diversity of patients and its influence on pharmacoepidemiological research

D4 - The diversity of social networks - Their influence on patient care

D6 - The emergence of biologicals as therapeutic agents

E2 - Interprofessional education

F14 - Process validation

F15 - Improving communication between healthcare providers in disaster situations

F16 - Pharmacists in humanitarian work

F19 - Presentations from FIP member organisations (Part 3)

F22 - Short oral presentations of the FIP Community Pharmacy Section

F26 - Report on the Pharmacopoeia Meeting in India

F6 - Creating the future leaders in pharmacy

Pharmabridge

September 5

C4 - Managing patients with asthma: The role of the pharmacist

C5 - Managing mentally ill patients: The role of the pharmacist

C9 - The role of compounding in closing therapeutic gaps (Parts 1 and 2)

D5 - Pharmacy Practice Research: Assessing the evidence and research needs of integrated care for complex patients

D7 - Fast forward to the future: Translating science into better patient care

D8 - How patient stratification and pharmacogenetics affect ADRs in complex patients

D9 - Individual therapy, individual care - optimization in the face of complexity

E4 - Addressing global complexities through educational innovation

F10 - Commitment to ethical responsibility and professional autonomy in pharmacy

F20 - Presentations from FIP member organisations (part 4)

F24 - Short oral presentations of the FIP Social and Administrative Pharmacy Section

F25 - History of Pharmacy

F27 - Short oral presentations of the FIP Academic Pharmacy Section

F7 - Leadership session for young leaders

Poster and Presentations

Academic Pharmacy

Academic Pharmacy: Addressing global complexities through educational innovation

Community Pharmacy

Formulation Design and Pharmaceutical Technology

Industrial Pharmacy

Pharmacy Information

Pharmacy Practice Research

Social and Administrative Pharmacy

Poster

Academic Pharmacy

Academic Pharmacy: Addressing global complexities through educational innovation

Analytical Sciences and Pharmaceutical Quality

Biotechnology

Clinical Biology

Community Pharmacy

Community Pharmacy: Emerging strategies for handling complex patients

Community Pharmacy: Unmet needs of complex patients

Community Pharmacy: What are we doing to meet the needs of complex patients?

Drug Design and Discovery

Formulation Design and Pharmaceutical Technology

History of Pharmacy

Hospital Pharmacy

Industrial Pharmacy

Laboratory and Medicines Control Services

Military & Emergency Pharmacy

Natural Products

Pharmacokinetics, Pharmacodynamics, Absorption, Distribution, Metabolism and Excretion

Pharmacy Information

Pharmacy Practice Research

Pharmacy Technicians

Regulatory Sciences

Social and Administrative Pharmacy

Translational Research and Individualized Medicines

Biography

Press

2012 Amsterdam (the Netherlands)

Presentations

October 3

8B1 (1) - 3rd AIM global deans forum (part 1) - Competenciesand the curriculum

8B1 (2) - 3rd AIM global deans forum (part 2) - Interprofessional education and success in pharmacy education and social accountability

8I (1) - FIP Symposium for Pharmacy technicians and pharmacy support workforce (part 1: the role of the pharmacy technician)

8I (2) - FIP Symposium for Pharmacy technicians and pharmacy support workforce (part 2: Education for pharmacy technician/support staff)

October 4

8A - Going Dutch: Pharmacy in the Netherlands

8B1 (3) - 3rd AIM global deans forum (part 3) - Global perspective on professional healthcare education

8D1 - Exploiting scientific knowledge of biological transporters for practical therapeutic benefit

8I (2) - FIP Symposium for Pharmacy technicians and pharmacy support workforce (part 2: Education for pharmacy technician/support staff)

October 5

1A - Improving patient outcomes through collaborative practice

1B - Pharmacy practice research – proving the value of the pharmacist now and in the future (part 1)

1B1 - Pharmacy practice research – proving the value of the pharmacist now and in the future (part 2)

1B2 - Pharmacy practice research – proving the value of the pharmacist now and in the future (part 2)

2A - The future of sustainable health and pharmacy care

2D - Diagnostics: directing individualised medicine into the future

3A - Reporting of adverse events and errors

3B - Risk benefits management in practice

4A - Increased legal, social and professional accountability: is the profession ready?

4C - Medicines information for consumers: partnering with patients to maximise benefits

5C - Emergency: not enough medicines - best case solutions in dealing with drug shortages

6C - Pharmacy law and competition law: feuding laws or working in partnership?

7B - Supporting adherence in community pharmacies

8C1 - Reports from your global network: FIP member organisations present their best cases and challenges

8C2 - Forum for policy makers - trends in community pharmacy: debating the future of the profession

8E - Breakfast session: pharmacists in humanitarian work

8H - WHO-FIP launch event: 2012 Global Pharmacy Workforce report

October 6

1C - Future directions – integrating multidisciplinary education into curricula

2B - The new medicines in 20 years time and their impact on pharmacy practice

2E - Pharmaceutical sciences: Past and future impact of drug development on health care

4D - The future of good pharmacy practice in community pharmacy: be part of the creation

4E - Social networks: friend or foe in medicines information?

4F - Steering better future decisions: comparative effectiveness research

5A - Are there global solutions to ensure the integrity of the global supply chain?

5B - The regulation of pharmaceuticals has significantly increased costs without addressing the key weaknesses in the supply chain

6A - Economics of healthcare: how will we afford health services

7A - Medication adherence: if you don’t take the medicines they won’t work!

8B5 - Short Oral Presentations of the FIP Academic Pharmacy Section

8C3 - Reports from our global network: FIP memmber organisations present their best cases and challenges

8C4 - Food for Thought- Lessons Learned from the Food Industry

8D2 - Looking into the future in pharmaceutical development, what is coming down the pipeline?

8F1 - From development to marketing - short oral communications

October 7

1D - Presentation of "community pharmacy vision 2020"

2C - What scientific principles will drug therapy be based on in 2030?

2F - The future of clinical pharmacy education: the need for attention to ‘hot topics’

2G - Biowaiver monographs: increasing access to the world’s affordable, quality medicines

3C - Pharmacists: Creating a Future of Better Pharmacovigilance

4B - Access to appropriate pain relief: a global challenge

4G - Clinical guidelines: raising the bar or creating roadblocks?

4H - Improving responsible use of OTC medicines from labelling to counselling

5D - The future emergency drug supply chain

5E - Current developments in quality assurance of the supply chain

6B - Economics of pharmacy: how will pharmacists be paid?

8B2 - Innovations in education technology for pharmacy and healthcare learners

8C5 - The future of emergency pharmacy practice and policy

8F2 - Forum for practitioners - oral communications: 100 community pharmacists talk: my daily activities

8J1 - International World of Pharmacopoeias: Now and In Future

8J2 - International World Pharmacopoeias: Good Pharmacopoeial Practices

October 8

1F - What does a pharmacy leader look like (and are they born, developed or adopted)?

2H - Breakthrough technologies and the paradigm shift in nanomedicines

3D - Pharmaceuticals and water

4I - The dynamic healthcare environment: its impact on the future

4J - Switching from prescription to non-prescription status: Challenges and opportunities

6D - Forum for innovators: integrating the professional and business demands of a successful pharmacy

8B3 - Universal competencies: what is competence and how do we measure it?

8B4 - The learning experience: assuring quality, satisfaction and better outcomes in global pharmacy education provision

8F3 - Short oral communications of the Pharmacy Information Section

8F4 - Clinical pearls: Inspiration to improve your future hospital practice

8F5 - Short Oral Communication of the Social and Administrative Pharmacy Section

8G - History of pharmacy

8J3 - International World Pharmacopoeias: Workshop on Impurities and Residues

8J4 - International World Pharmacopoeias: Workshop on Challenges in Developing Herbal Medicines Monographs and Applying them in Practice

8J5 - International World of Pharmacopoeias. Now and In Future: The way forward

Poster and Presentations

Academic Pharmacy: Competency and pharmacy education

Academic Pharmacy: Hot topics in Clinical Pharmacy Education

Academic Pharmacy: Other

Community Pharmacy

Hospital Pharmacy

Pharmacy Information

SIG: Analytical Sciences and Pharmaceutical Quality

Social and Administrative Pharmacy

Poster

Academic Pharmacy: Competency and pharmacy education

Academic Pharmacy: Hot topics in Clinical Pharmacy Education

Academic Pharmacy: Other

Academic Pharmacy: Quality assurance and the student learning experience

Clinical Biology

Community Pharmacy

Community Pharmacy: Compounding

Community Pharmacy: Counselling activities and supporting adherence

Community Pharmacy: Dispensing activities (processes)

Community Pharmacy: GPP

Community Pharmacy: Pharmacy services

History of Pharmacy

Hospital Pharmacy

Industrial Pharmacy

Laboratory and Medicines Control Services

Military & Emergency Pharmacy

Pharmacy Information

Pharmacy Technicians

SIG: Analytical Sciences and Pharmaceutical Quality

SIG: Biotechnology

SIG: Drug Design and Discovery

SIG: Formulation Design and Pharmaceutical Technology

SIG: Natural Products

SIG: Pharmacokinetics, Pharmacodynamics, Absorption, Distribution, Metabolism and Excretion

SIG: Regulatory Sciences

SIG: Translational Research and Individualized Medicines

Social and Administrative Pharmacy

Biography

Press

2011 Hyderabad (India)

Presentations

September 3

R1 - Pharmacovigilance and Medicines Information to Enhance Patient Safety

September 5

A1 - A primer on quality and safety

B1 - Environment and pharmaceuticals

C1 - WHO Guidelines on multisource drugs and interchangeability

C2 - Biosimilars

D1 - Forum for innovators in pharmacy practice (part 1)

D2 - Forum for innovators in pharmacy practice (part 2)

D3 - Clinical Biology in India health care system: Organisation and contribution

F1 - Careers and leadership in pharmacy and education

F2 - Generic and patient experience

F9 - FIP Member organisations presenting national updates (part 1)

FIP Host Madsen Award Lecture

J1 - Building practitioner's skills

J2 - Your career in Industrial Pharmacy - From drug development to drug distribution

J3 - Regulatory and legislative changes from across the world

J4 - Pharmacogenomics in oncology

J5 - Careering toward advanced levels of practice

J6 - Communicating basic medicines information to patients

September 6

A2 - Learning from errors and monitoring safety

C3 - Clinical research

C4 - Paradigm shift in research and development

D10 - Recent advances and challenges in the safe preparation of cytotoxic agents

D4 - Current Issues Session - Vulnerable populations

D5 - Solving tableting problems

D6 - Basel statements in developing and developed countries

D7 - A glimpse of Community Pharmacy in 2020

D9 - Medication safety and risk management

F10 - FIP Member organisations presenting national updates (part 2)

F12 - FIP Symposium on counterfeit medicines

F3 – FIP/WHO Symposium on Engaging Pharmacists in Tuberculosis care and control

F4 - Report of the WG on Maternal, Newborn and Children Health

F5 - Outcomes of the Pharmacy Education Taskforce: a report, review and reflection

J7 - Trends in Community Pharmacy - Debating the future of the profession: Forum for policy makers

J8 - Competition - Short Oral Communications of the FIP Industrial Pharmacy Section

September 7

A3 - Building a safer service: Techniques and tools to improve quality and safety

A4 - Paying pharmacists for patient outcomes

C5 - Pharmaceutical manufacturing

C6 - Standardization of herbal products

D11 - Practitioners' day (part 1)

D12 - Practitioners' day (part 2)

D13 - Innovations to improve teaching and learning

D14 - Quality and safety in pharmacologistics

D23 - Communication and Control in an Operational Setting

F11 - FIP Member organisations presenting national updates (part 3)

F6 - Mapping a new vision - Translating ideas into practice

J10 - Building a 'Toolbox' for practitioner development and support

J12 - Pharmaceuticals in the Environment

J9 - Pediatric medicines - Challenges and opportunities

September 8

C7 - Dissolution: The pivotal tool for developing quality drugs

D15 - Pharmacists and mass communication - A job that needs to be done continuously

D16 - Short oral communications of the FIP Social and Administrative Pharmacy Section

D17 - Good Manufacturing Practices - Expectations for the coming decade (part I)

D18 - Good Manufacturing Practices - Expectations for the coming decade (part II)

D19 - Ask your pharmacist Day (part 1) - Immunizations in community pharmacy - Ask your pharmacist!

D20 - Ask your pharmacist Day (part 2) - Healthy travelling? - Ask your pharmacist!

D21 - Short oral communications of the Academic Pharmacy Section

F7 - Symposium on the History of Pharmacy

J13 - Developing young academics through networking and mentoring

J14 - Pharmacovigilance

Poster and Presentations

Academic Pharmacy

Community Pharmacy - Collaborative Care

Community Pharmacy - Good Pharmacy Practice

Community Pharmacy - Primary Care Activities

Community Pharmacy - Quality and Safety

Industrial Pharmacy

Pharmacy Information

Social and Administrative Pharmacy

Poster

Academic Pharmacy

Bioavailability/Bioequivalence

Biopharmaceutics Classification System / Biowaiver

Clinical Biology

Community Pharmacy - Collaborative Care

Community Pharmacy - Good Pharmacy Practice

Community Pharmacy - Other

Community Pharmacy - Primary Care Activities

Community Pharmacy - Quality and Safety

Dissolution / Drug Release

Hospital Pharmacy